US Healthcare Journal
SEE OTHER BRANDS

Get your fresh news on healthcare and wellness in the United States

US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on April 10, 2025

Bierman Autism Centers Celebrates Grand Opening of West Orange, NJ Location with a Sensory-Friendly Barnyard Bash

Bierman Autism Centers Celebrates Grand Opening of West Orange, NJ Location with a Sensory-Friendly Barnyard Bash

Join us for a fun-filled Petting Zoo event on April 26—with crafts, treats, furry friends, and a special appearance by the Mayor of West Orange! WEST ORANGE, NJ, UNITED STATES, April 10, 2025 /⁨EINPresswire.com⁩/ -- The barnyard is coming to town! Bierman …

Passing of former Chief Executive Officer, Dr. Loressa Cole

Passing of former Chief Executive Officer, Dr. Loressa Cole

SILVER SPRING, MD, April 10, 2025 (GLOBE NEWSWIRE) -- It is with profound sadness that we share the passing of our former Chief Executive Officer, Loressa Cole, DNP, MBA, RN, NEA-BC, FAAN, FACHE.  Loressa was a beloved member of the American Nurses …

Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event

Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event

BOSTON, MA, April 10, 2025 (GLOBE NEWSWIRE) -- Odylia Therapeutics (Odylia) a nonprofit biotechnology company dedicated to expediting drug development for rare diseases, hosted a Rare Disease Day event to foster conversations about new funding models and …

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced its …

Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

Venus Concept Announces Closing of $1.1 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

TORONTO, April 10, 2025 (GLOBE NEWSWIRE) --  Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the closing of its previously announced registered direct offering priced at- …

BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025

BrightSpring Health Services, Inc. to Announce First Quarter 2025 Financial Results on May 2, 2025

LOUISVILLE, Ky., April 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that it plans to release its first quarter 2025 financial results on Friday, May 2, 2025, prior to the …

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DUBLIN, April 10, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non- …

Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting

Protara Therapeutics to Present Interim Analysis from the Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the American Urological Association Annual Meeting

NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that two presentations and a panel …

Folia Health Expands Its Rare Renal Disease Research with a New C3G Study to Assess Real-World Disease Impact

Folia Health Expands Its Rare Renal Disease Research with a New C3G Study to Assess Real-World Disease Impact

BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Folia Health launches enrollment for an innovative, at-home real-world evidence initiative for individuals with C3 glomerulopathy (C3G). Designed in partnership with C3G clinicians and patients, this study uses …

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas

SAN JOSE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company, whose mission is to revolutionize BPH treatment globally, announced today it will host an in-person investor …

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings

WALTHAM, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer

Filing provisional patent application with the USPTO entitled “PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy” key to advancement of Diagnostic and Therapeutic programs Dr. Alan Kozikowski, internationally acclaimed pioneer in the …

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry Conferences

MARIETTA, Ga., April 10, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will participate in the following industry conferences this quarter to feature the latest scientific and clinical data …

Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

FORT WORTH, TX, April 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical …

Global DLIF XLIF Implants Market Sees Growth Amid Rising Spinal Disorders and Technological Innovations

Global DLIF XLIF Implants Market Sees Growth Amid Rising Spinal Disorders and Technological Innovations

The market is driven by the rising demand for minimally invasive surgical techniques and the adoption of innovative implant solutions in spine surgeries. VANCOUVER, BRITISH COLUMBIA, CANADA, April 10, 2025 /⁨EINPresswire.com⁩/ -- The dlif xlif implants …

Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights

Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights

EXTON, PA, April 10, 2025 (GLOBE NEWSWIRE) -- As treatment approaches for cutaneous lupus erythematosus (CLE) continue to evolve, new data from Spherix Global Insights shed light on how specialists are currently managing the condition—and where emerging …

Healthcare Reimbursement Market Growth Research Report 2024-2033 | 250 Pages

Healthcare Reimbursement Market Growth Research Report 2024-2033 | 250 Pages

The Healthcare Reimbursement market is expected to grow from an estimated USD 22.6 billion in 2024 to USD 104.1 billion in 2033, at a CAGR of 18.50%. VANCOUVER, BC, CANADA, April 10, 2025 /⁨EINPresswire.com⁩/ -- The Healthcare Reimbursement market is …

Healthcare Payer Services Market Growth Research Report 2024-2033 | 250 Pages

Healthcare Payer Services Market Growth Research Report 2024-2033 | 250 Pages

The Healthcare Payer Services market is expected to grow from an estimated USD 76.4 billion in 2024 to USD 177.2 billion in 2033, at a CAGR of 9.80%. VANCOUVER, BC, CANADA, April 10, 2025 /⁨EINPresswire.com⁩/ -- The Healthcare Payer Services market is …

The Guardian Group Announces its STATE OF QME REPORTING 2025: Stakeholder Survey Report

The Guardian Group Announces its STATE OF QME REPORTING 2025: Stakeholder Survey Report

Santa Ana, Ca, April 10, 2025 (GLOBE NEWSWIRE) -- The Guardian Group, LCC, a leading firm in the medical-legal industry, today released: “STATE OF QME REPORTING 2025 " its annual report that explores the utility and effectiveness of QME Reports throughout …

Credex Healthcare Launches New Staffing Solutions for Credentialing and Enrollment Services Nationwide

Credex Healthcare Launches New Staffing Solutions for Credentialing and Enrollment Services Nationwide

Jacksonville, Fl , April 10, 2025 (GLOBE NEWSWIRE) -- National leader in medical staff credentialing and enrollment solutions, Credex Healthcare, is proud to announce the launch of its Credentialing Staffing Solutions. This scalable staffing service is …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service